Rentokil Initial Financials
RTO Stock | USD 25.98 0.36 1.41% |
Current Value | Last Year | Change From Last Year | 10 Year Trend | ||||||
---|---|---|---|---|---|---|---|---|---|
Current Ratio | 1.17 | 1.0458 |
|
|
The essential information of the day-to-day investment outlook for Rentokil Initial includes many different criteria found on its balance sheet. An individual investor should monitor Rentokil Initial's cash flow, debt, and profitability to accurately make informed decisions on whether to invest in Rentokil Initial.
Cash And Equivalents |
|
Rentokil | Select Account or Indicator |
Understanding current and past Rentokil Initial Financials, including the trends in assets, liabilities, equity and income are directly related to making proper and timely investing decisions. All of Rentokil Initial's financial statements are interrelated, with each one affecting the others. For example, an increase in Rentokil Initial's assets may result in an increase in income on the income statement.
Rentokil Initial Stock Summary
Rentokil Initial competes with Cass Information, First Advantage, CBIZ, Civeo Corp, and Performant Financial. Rentokil Initial plc, together with its subsidiaries, provides route-based services in North America, the United Kingdom, rest of Europe, Asia, the Pacific, and internationally. Rentokil Initial plc was founded in 1903 and is headquartered in Crawley, the United Kingdom. Rentokil Initial operates under Specialty Business Services classification in the United States and is traded on New York Stock Exchange. It employs 46000 people.Foreign Associates | |
Specialization | Industrials, Commercial & Professional Services |
Instrument | USA Stock View All |
Exchange | New York Stock Exchange |
CUSIP | 760125104 |
Location | United Kingdom |
Business Address | Compass House, Crawley, |
Sector | Commercial Services & Supplies |
Industry | Industrials |
Benchmark | Dow Jones Industrial |
Website | www.rentokil-initial.com |
Phone | 44 12 9385 8000 |
Currency | USD - US Dollar |
Rentokil Initial Key Financial Ratios
Return On Equity | 0.0966 | ||||
Profit Margin | 0.07 % | ||||
Operating Margin | 0.13 % | ||||
Price To Sales | 2.41 X | ||||
Revenue | 5.38 B |
Rentokil Initial Key Balance Sheet Accounts
2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
Total Assets | 4.3B | 5.6B | 4.3B | 11.9B | 11.1B | 11.7B | |
Other Current Liab | 426.7M | 697M | 687.1M | 954M | 627M | 455.8M | |
Net Debt | 1.1B | 1.2B | 1.3B | 3.2B | 3.2B | 3.3B | |
Retained Earnings | 2.8B | 3.0B | 3.2B | 6.3B | 6.5B | 6.8B | |
Accounts Payable | 187.9M | 102.3M | 104M | 351M | 357M | 234.0M | |
Cash | 1.2B | 1.9B | 668.4M | 2.2B | 1.6B | 1.6B | |
Inventory | 106.5M | 131.3M | 135.7M | 200M | 207M | 217.4M | |
Total Liab | 3.3B | 4.5B | 3.1B | 7.8B | 7.0B | 7.4B | |
Total Current Assets | 1.8B | 2.8B | 1.3B | 3.2B | 2.7B | 2.8B | |
Short Term Debt | 1.0B | 1.7B | 538M | 1.5B | 1.3B | 1.4B | |
Intangible Assets | 1.7B | 1.9B | 2.2B | 7.3B | 2.0B | 2.1B | |
Other Current Assets | 200K | 81.2M | 8.9M | 36M | 33M | 31.4M | |
Net Receivables | 507.7M | 504.6M | 527M | 830M | 880M | 924M | |
Good Will | 1.3B | 1.6B | 1.8B | 5.1B | 5.0B | 5.3B | |
Other Assets | 158.5M | 150.2M | 173.3M | 67M | 60.3M | 57.3M | |
Long Term Debt | 1.1B | 1.3B | 1.3B | 3.6B | 3.2B | 1.9B | |
Long Term Debt Total | 1.2B | 1.5B | 1.4B | 3.9B | 4.5B | 4.7B | |
Net Tangible Assets | (658M) | (779.8M) | (886.3M) | (3.2B) | (2.9B) | (2.7B) | |
Net Invested Capital | 2.1B | 4.3B | 3.0B | 9.0B | 8.4B | 5.3B | |
Short Long Term Debt | 84.6M | 1.8B | 459.3M | 1.4B | 1.1B | 915.8M |
Rentokil Initial Key Income Statement Accounts
2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
Interest Expense | 38.2M | 40.3M | 33.3M | 74M | 189M | 198.5M | |
Total Revenue | 2.7B | 2.8B | 3.0B | 3.7B | 5.4B | 5.6B | |
Gross Profit | 577.2M | 653M | 714.8M | 977M | 1.5B | 1.4B | |
Operating Income | 254.7M | 301M | 366.2M | 498M | 625M | 656.3M | |
Ebit | 254.7M | 256.3M | 329.5M | 381M | 682M | 716.1M | |
Ebitda | 580.6M | 581M | 656M | 767M | 1.2B | 1.2B | |
Income Before Tax | 323.3M | 221.5M | 317M | 287M | 493M | 517.7M | |
Net Income | 283.8M | 186M | 263M | 232M | 381M | 193.0M | |
Income Tax Expense | 54.7M | 43.5M | 61.9M | 64M | 112M | 60.4M | |
Cost Of Revenue | 2.1B | 2.1B | 2.2B | 2.7B | 3.9B | 4.1B | |
Tax Provision | 54.7M | 43.5M | 61.9M | 64M | 112M | 117.6M | |
Interest Income | 9.9M | 10.2M | 1M | 21M | 25M | 14.1M | |
Net Interest Income | (44.6M) | (34.7M) | (32.6M) | (72M) | (164M) | (155.8M) |
Rentokil Initial Key Cash Accounts
2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
Change In Cash | 173M | 780.3M | (308.9M) | 637M | (47M) | (44.7M) | |
Free Cash Flow | 292M | 382.6M | 403.3M | 410M | 530M | 556.5M | |
Depreciation | 305M | 324.7M | 297.9M | 364M | 592M | 621.6M | |
Other Non Cash Items | (200.5M) | 635.1M | (100M) | (78M) | (440M) | (418M) | |
Capital Expenditures | 170.9M | 152.5M | 159.9M | 190M | 211M | 189.1M | |
Net Income | 369.4M | 185.9M | 346.5M | 317M | 625M | 656.3M | |
End Period Cash Flow | 273.9M | 1.9B | 241.9M | 879M | 832M | 873.6M | |
Dividends Paid | 74.2M | 85.8M | 138.7M | 122M | 201M | 107.7M | |
Net Borrowings | (124.5M) | 277.2M | (249.9M) | 1.4B | 1.7B | 1.7B |
Rentokil Financial Ratios Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Rentokil Initial's current stock value. Our valuation model uses many indicators to compare Rentokil Initial value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Rentokil Initial competition to find correlations between indicators driving Rentokil Initial's intrinsic value. More Info.Rentokil Initial PLC is rated below average in return on equity category among its peers. It is rated second in return on asset category among its peers reporting about 0.43 of Return On Asset per Return On Equity. The ratio of Return On Equity to Return On Asset for Rentokil Initial PLC is roughly 2.35 . At this time, Rentokil Initial's Return On Equity is very stable compared to the past year. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Rentokil Initial's earnings, one of the primary drivers of an investment's value.Rentokil Initial PLC Systematic Risk
Rentokil Initial's systematic risk plays a vital role in portfolio allocation when considering its stock to be added to a well-diversified portfolio. Rentokil Initial volatility which cannot be eliminated through diversification, requires returns over the risk-free rate. Over the long run, a well-diversified portfolio provides returns that match its exposure to systematic risk. In this case, investors face a trade-off between expected returns and systematic risk and, therefore, can only reduce a portfolio's exposure to systematic risk by sacrificing expected returns on the portfolio.
The output start index for this execution was twelve with a total number of output elements of fourty-nine. The Beta measures systematic risk based on how returns on Rentokil Initial PLC correlated with the market. If Beta is less than 0 Rentokil Initial generally moves in the opposite direction as compared to the market. If Rentokil Initial Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one Rentokil Initial PLC is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of Rentokil Initial is generally in the same direction as the market. If Beta > 1 Rentokil Initial moves generally in the same direction as, but more than the movement of the benchmark.
Today, most investors in Rentokil Initial Stock are looking for potential investment opportunities by analyzing not only static indicators but also various Rentokil Initial's growth ratios. Consistent increases or decreases in fundamental ratios usually indicate a possible pattern that can be successfully translated into profits. However, when comparing two companies, knowing each company's growth growth rates may not be enough to decide which company is a better investment. That's why investors frequently use static breakdown of Rentokil Initial growth as a starting point in their analysis.
Price Earnings To Growth Ratio |
|
Rentokil Initial November 25, 2024 Opportunity Range
Along with financial statement analysis, the daily predictive indicators of Rentokil Initial help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of Rentokil Initial PLC. We use our internally-developed statistical techniques to arrive at the intrinsic value of Rentokil Initial PLC based on widely used predictive technical indicators. In general, we focus on analyzing Rentokil Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Rentokil Initial's daily price indicators and compare them against related drivers.
Information Ratio | (0.13) | |||
Maximum Drawdown | 22.43 | |||
Value At Risk | (2.69) | |||
Potential Upside | 2.4 |
Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Rentokil Initial PLC. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in estimate. You can also try the Instant Ratings module to determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance.
Is Environmental & Facilities Services space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Rentokil Initial. If investors know Rentokil will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Rentokil Initial listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth 0.06 | Dividend Share 0.091 | Earnings Share 0.98 | Revenue Per Share 10.735 | Quarterly Revenue Growth 0.013 |
The market value of Rentokil Initial PLC is measured differently than its book value, which is the value of Rentokil that is recorded on the company's balance sheet. Investors also form their own opinion of Rentokil Initial's value that differs from its market value or its book value, called intrinsic value, which is Rentokil Initial's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Rentokil Initial's market value can be influenced by many factors that don't directly affect Rentokil Initial's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Rentokil Initial's value and its price as these two are different measures arrived at by different means. Investors typically determine if Rentokil Initial is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Rentokil Initial's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.